These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19621068)

  • 1. Focusing on quality patient care in the new global subsidy for malaria medicines.
    Moon S; Pérez Casas C; Kindermans JM; de Smet M; von Schoen-Angerer T
    PLoS Med; 2009 Jul; 6(7):e1000106. PubMed ID: 19621068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why the world needs another malaria initiative.
    Lancet; 2004 Jul 31-Aug 6; 364(9432):389-90. PubMed ID: 15288715
    [No Abstract]   [Full Text] [Related]  

  • 3. Universal access to malaria medicines: innovation in financing and delivery.
    Adeyi O; Atun R
    Lancet; 2010 Nov; 376(9755):1869-71. PubMed ID: 20940074
    [No Abstract]   [Full Text] [Related]  

  • 4. Subsidising artemisinin-based combination therapy in the private retail sector.
    Opiyo N; Yamey G; Garner P
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of the Affordable Medicines for Malaria Facility (AMFm) in Ghana: processes, challenges and achievements.
    Malm KL; Segbaya S; Forson I; Gakpey KD; Sampong LB; Adjei EA; Bart-Plange C
    J Public Health Policy; 2013 May; 34(2):302-14. PubMed ID: 23575513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the AMFm.
    Tren R; Hess K
    Lancet; 2011 Mar; 377(9768):810; author reply 810-1. PubMed ID: 21377565
    [No Abstract]   [Full Text] [Related]  

  • 7. Qinghaosu (artemisinin): the price of success.
    White NJ
    Science; 2008 Apr; 320(5874):330-4. PubMed ID: 18420924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Affordable Medicines Facility-malaria--a success in peril.
    Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
    Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making antimalarial agents available in Africa.
    Arrow KJ; Gelband H; Jamison DT
    N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
    [No Abstract]   [Full Text] [Related]  

  • 10. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
    Laxminarayan R; Over M; Smith DL
    Health Aff (Millwood); 2006; 25(2):325-36. PubMed ID: 16522574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malaria plan under scrutiny.
    Maxmen A
    Nature; 2012 Oct; 490(7418):13-4. PubMed ID: 23038440
    [No Abstract]   [Full Text] [Related]  

  • 12. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
    Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
    Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating the AMFm message: exploring the effect of communication and training interventions on private for-profit provider awareness and knowledge related to a multi-country anti-malarial subsidy intervention.
    Willey BA; Tougher S; Ye Y; ; Mann AG; Thomson R; Kourgueni IA; Amuasi JH; Ren R; Wamukoya M; Rueda ST; Taylor M; Seydou M; Nguah SB; Ndiaye S; Mberu B; Malam O; Kalolella A; Juma E; Johanes B; Festo C; Diap G; Diallo D; Bruxvoort K; Ansong D; Amin A; Adegoke CA; Hanson K; Arnold F; Goodman C
    Malar J; 2014 Feb; 13():46. PubMed ID: 24495691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.
    Yeung S; Patouillard E; Allen H; Socheat D
    Malar J; 2011 Aug; 10():243. PubMed ID: 21851625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health. Optimizing investments in malaria treatment and diagnosis.
    Cohen JM; Woolsey AM; Sabot OJ; Gething PW; Tatem AJ; Moonen B
    Science; 2012 Nov; 338(6107):612-4. PubMed ID: 23118172
    [No Abstract]   [Full Text] [Related]  

  • 16. Global fund switches to artemisinin.
    Shetty P
    Lancet Infect Dis; 2004 Aug; 4(8):477. PubMed ID: 15298018
    [No Abstract]   [Full Text] [Related]  

  • 17. A global subsidy: key to affordable drugs for malaria?
    Laxminarayan R; Gelband H
    Health Aff (Millwood); 2009; 28(4):949-61. PubMed ID: 19597193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
    Matowe L; Adeyi O
    Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to accusations of medical malpractice by WHO and the Global Fund.
    Nafo-Traoré F
    Lancet; 2004 Jan; 363(9406):397. PubMed ID: 15070574
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of the Affordable Medicines Facility--malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data.
    Tougher S; ; Ye Y; Amuasi JH; Kourgueni IA; Thomson R; Goodman C; Mann AG; Ren R; Willey BA; Adegoke CA; Amin A; Ansong D; Bruxvoort K; Diallo DA; Diap G; Festo C; Johanes B; Juma E; Kalolella A; Malam O; Mberu B; Ndiaye S; Nguah SB; Seydou M; Taylor M; Rueda ST; Wamukoya M; Arnold F; Hanson K
    Lancet; 2012 Dec; 380(9857):1916-26. PubMed ID: 23122217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.